Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
A New Treatment Option Approved for Some Advanced Breast Cancers: What Patients Should Know About REVTORPYK
The FDA has approved REVTORPYK™ (gedatolisib) for certain people with HR-positive, HER2-negative advanced breast cancer whose tumors lack a PIK3CA mutation and whose cancer has progressed after hormone therapy. Learn who may benefit and what this new treatment means.
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
